scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.RBMO.2014.07.022 |
P8608 | Fatcat ID | release_3h7vqwbcqfbbbmahagkqiltmse |
P698 | PubMed publication ID | 25246114 |
P2093 | author name string | Ali Sami Gurbuz | |
Ahmet Zeki Isik | |||
Necati Ozcimen | |||
Funda Gode | |||
P433 | issue | 5 | |
P921 | main subject | ovarian hyperstimulation syndrome | Q1760461 |
P304 | page(s) | 541-544 | |
P577 | publication date | 2014-08-13 | |
P1433 | published in | Reproductive BioMedicine Online | Q15762964 |
P1476 | title | Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases | |
P478 | volume | 29 |
Q90259787 | A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL |
Q38685318 | A fresh look at the freeze-all protocol: a SWOT analysis |
Q46788717 | A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols. |
Q38371465 | A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial |
Q48566514 | Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases |
Q38829575 | An update on the prevention of ovarian hyperstimulation syndrome |
Q37042732 | Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS. |
Q48510192 | Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation. |
Q43206166 | Does freeze all policy eliminate OHSS??? "It ain't necessarily so…". |
Q36060453 | Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy |
Q33770533 | GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis |
Q28077044 | GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article |
Q88990735 | Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles |
Q41223889 | Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders |
Q36756209 | Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology? |
Q58701046 | Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome |
Q57177405 | Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment |
Q35938164 | Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition |
Q38876689 | Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials |
Q33743109 | Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literature |
Q48218793 | Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome. |
Q93358265 | Rare genetic variants potentially involved in ovarian hyperstimulation syndrome |
Q28084432 | Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic |
Q38716011 | The high responder: a review of pathophysiology and outcomes during IVF treatment |
Q47599593 | The number of oocytes retrieved during IVF: a balance between efficacy and safety |
Q38954609 | The state of "freeze-for-all" in human ARTs |
Q38677963 | What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study. |
Q36378491 | Why more is less and less is more when it comes to ovarian stimulation |
Search more.